Insight Molecular Diagnostics Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/877d4a8e-588a-426a-887e-231fcbfe47bd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-51.1M | 2025-01-01 – 2025-12-31 | evidence 0001642380-26-000004 |
| FY 2024 | $-61.0M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-043852 |
| FY 2023 | $-25.1M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014720 |
| FY 2022 | $-18.0M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-012005 |
| FY 2021 | $-53.7M | 2021-01-01 – 2021-12-31 | evidence 0001493152-23-012005 |
| FY 2020 | $-29.7M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006465 |
| FY 2019 | $-22.2M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004738 |
| FY 2018 | $-15.2M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004549 |
| FY 2017 | $-18.8M | 2017-01-01 – 2017-12-31 | evidence 0001140361-18-016477 |
| FY 2016 | $-11.1M | 2016-01-01 – 2016-12-31 | evidence 0001140361-17-009369 |
| FY 2015 | $-8.7M | 2015-01-01 – 2015-12-31 | evidence 0001140361-17-009369 |
| FY 2014 | $-5.0M | 2014-01-01 – 2014-12-31 | evidence 0001140361-17-009369 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Insight Molecular Diagnostics Inc. — all facts · Revenue · Net Income